NSE
Alkem Laboratories LimitedALKEM
Alkem Laboratories is a leading branded-generics company in India.
| Key products | Acute & chronic branded generics (Clavam, Pan-D), US generics. |
|---|---|
| Geography | India and the US. |
| Competitors | Sun Pharma, Mankind, Cipla. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹103.5 Cr
Institutional buyers
16 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ALKEMThis | +₹1,013.7 Cr | 13 | — | — | -2 | 6 |
| 2 | CIPLA | — | — | — | — | +19 | 44 |
| 3 | DRREDDY | — | — | — | — | +20 | 46 |
| 4 | SUNPHARMA | — | — | — | — | +15 | 45 |
| 5 | TORNTPHARM | — | — | — | — | — | — |
| 6 | LUPIN | — | — | — | — | — | — |
| 7 | ZYDUSLIFE | — | — | 1 | +1 | — | — |
| 8 | AUROPHARMA | — | — | — | — | — | — |
| 9 | MANKIND | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • [object Object]
- • [object Object]
- • [object Object]
- • [object Object]
Weaknesses
- • [object Object]
- • [object Object]
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-06-15FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-10FilingAlkem Laboratories Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-02BulkBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
- 2026-06-02BulkSELL · ₹643.9 CrJAYANTI SINHA
- 2026-06-02BlockBUY · ₹25 CrBNP PARIBAS ARBITRAGE - ODI
- 2026-06-02BlockBUY · ₹45 CrDSP MUTUAL FUND
- 2026-06-02BlockBUY · ₹25 CrEDELWEISS MUTUAL FUND
- 2026-06-02BlockBUY · ₹25 CrGOLDMAN SACHS BANK EUROPE SE
- 2026-06-02BlockBUY · ₹265 CrHDFC MUTUAL FUND
- 2026-06-02BlockBUY · ₹469.8 CrICICI PRUDENTIAL MUTUAL FUND
- 2026-06-02BlockSELL · ₹643.9 CrJAYANTI SINHA
- 2026-06-02BlockBUY · ₹25 CrMORGAN STANLEY ASIA SINGAPORE PTE
- 2026-06-02BlockBUY · ₹25 CrNIPPON INDIA MUTUAL FUND
- 2026-06-02BlockSELL · ₹286 CrSAMPRADA&NANHAMATI SINGH FAMILY TRUST
- 2026-06-02BlockBUY · ₹25 CrSOCIETE GENERALE
- 2026-06-02NetDay net −₹174 Cr
- 2026-06-01NewsAlkem Laboratories to open trading window on June 1, 2026scanx.trade
- 2026-05-31NewsEarnings Miss: Alkem Laboratories Limited Missed EPS By 8.9% And Analysts Are Revising Their Forecastssimplywall.st
- 2026-05-25NewsAlkem Laboratories schedules meeting with SBI Mutual Fundscanx.trade
- 2026-05-12NewsAlkem Laboratories stock (INE540L01014): Indian pharma leader near 52-week highsAD HOC NEWS
- 2026-04-24NewsAlkem Labs CEO Dr. Vikas Gupta resigns; stock falls nearly 3%BusinessLine
- 2026-02-13NewsAlkem Laboratories Limited's (NSE:ALKEM) Share Price Not Quite Adding Upsimplywall.st
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 2
13 deals · 2026-06-02 → 2026-06-02
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-06-02 | ICICI PRUDENTIAL MUTUAL FUND | Institution | BUY | ₹469.8 Cr |
| 2026-06-02 | JAYANTI SINHA | HNI / other | SELL | ₹643.9 Cr |
| 2026-06-02 | BNP PARIBAS ARBITRAGE - ODI | HNI / other | BUY | ₹25 Cr |
| 2026-06-02 | DSP MUTUAL FUND | Institution | BUY | ₹45 Cr |
| 2026-06-02 | EDELWEISS MUTUAL FUND | Institution | BUY | ₹25 Cr |
| 2026-06-02 | GOLDMAN SACHS BANK EUROPE SE | HNI / other | BUY | ₹25 Cr |
| 2026-06-02 | HDFC MUTUAL FUND | Institution | BUY | ₹265 Cr |
| 2026-06-02 | ICICI PRUDENTIAL MUTUAL FUND | Institution | BUY | ₹469.8 Cr |
| 2026-06-02 | JAYANTI SINHA | HNI / other | SELL | ₹643.9 Cr |
| 2026-06-02 | MORGAN STANLEY ASIA SINGAPORE PTE | HNI / other | BUY | ₹25 Cr |
13 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on ALKEM
RSS News
6scanx.trade · 1/6/2026
▼simplywall.st · 31/5/2026
scanx.trade · 25/5/2026
AD HOC NEWS · 12/5/2026
▼BusinessLine · 24/4/2026
simplywall.st · 13/2/2026
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.